Wordt geladen...
Prasugrel in critically ill patients
While prasugrel is indicated for the treatment of myocardial infarction, its effects in the most severely affected patients requiring intensive care is unknown, so that we measured the antiplatelet effects and sparse pharmacokinetics of prasugrel in critically ill patients. Twenty-three patients adm...
Bewaard in:
| Gepubliceerd in: | Thromb Haemost |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Schattauer GmbH
2017
|
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6292180/ https://ncbi.nlm.nih.gov/pubmed/28692105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1160/TH17-03-0154 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|